- Home
- DHAI vs YI Comparison
DHAI vs YI Comparison
Compare DHAI & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHAI
- YI
- Stock Information
- Founded
- DHAI 2007
- YI 2010
- Country
- DHAI United States
- YI China
- Employees
- DHAI N/A
- YI N/A
- Industry
- DHAI
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- DHAI
- YI Consumer Staples
- Exchange
- DHAI NYSE
- YI Nasdaq
- Market Cap
- DHAI 55.5M
- YI 64.4M
- IPO Year
- DHAI N/A
- YI N/A
- Fundamental
- Price
- DHAI $0.92
- YI $0.67
- Analyst Decision
- DHAI
- YI
- Analyst Count
- DHAI 0
- YI 0
- Target Price
- DHAI N/A
- YI N/A
- AVG Volume (30 Days)
- DHAI 18.6K
- YI 108.0K
- Earning Date
- DHAI 08-19-2024
- YI 11-27-2024
- Dividend Yield
- DHAI N/A
- YI N/A
- EPS Growth
- DHAI N/A
- YI N/A
- EPS
- DHAI N/A
- YI N/A
- Revenue
- DHAI $67,615,000.00
- YI $2,026,540,888.00
- Revenue This Year
- DHAI N/A
- YI $61.85
- Revenue Next Year
- DHAI N/A
- YI N/A
- P/E Ratio
- DHAI N/A
- YI N/A
- Revenue Growth
- DHAI 14.15
- YI 0.38
- 52 Week Low
- DHAI $0.72
- YI $0.55
- 52 Week High
- DHAI $3.67
- YI $2.38
- Technical
- Relative Strength Index (RSI)
- DHAI 27.12
- YI 40.74
- Support Level
- DHAI $1.00
- YI $0.65
- Resistance Level
- DHAI $1.40
- YI $0.70
- Average True Range (ATR)
- DHAI 0.12
- YI 0.04
- MACD
- DHAI -0.01
- YI -0.01
- Stochastic Oscillator
- DHAI 16.00
- YI 12.60
About DHAI DIH HOLDINGS US INC
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.